CIHI developed the National Prescription Drug Utilization Information System (NPDUIS) in consultation with the Patented Medicine Prices Review Board (PMPRB).
NPDUIS houses pan-Canadian prescription drug claims-level data, focusing primarily on publicly financed drug benefit programs. The database includes the following:
- Claims data — Cost and utilization information on prescribed drugs. This information is used to measure and analyze prescription drug use in Canada.
- Formulary data — Information on which drugs are included in public drug programs in Canada and how they are covered.
- Drug product information — Used to identify drug products in a standardized format.
- Plan information — An outline of the administrative policies of public drug plans or programs in Canada. This data may help explain differences in drug utilization patterns across the country.
We welcome your feedback and questions
- Contact us at email@example.com.
Have a data inquiry or research question? Make a custom data request.
Information on NPDUIS
- National Prescription Drug Utilization Information System Plan Information Document, July 2018
- National Prescription Drug Utilization Information System Database-Plan Information: Summary of Changes, July 2018
- Drug use among seniors in Canada (May 2018)
- Prescribed Drug Spending in Canada, 2017: A Focus on Public Drug Programs (Nov 2017) (formerly Drug Expenditure in Canada)
- Use of Antipsychotics Among Seniors Living in Long-Term Care Facilities, 2014 (Feb 2016)
- Persistence and Compliance With Cardiovascular Drug Therapy Among Seniors (Feb 2015)
- Drug Use Among Seniors on Public Drug Programs in Canada, 2012 (May 2014)
- Brief to the Standing Senate Committee on Social Affairs, Science and Technology (Jan 2014)
Metadata is information about data. It helps users understand and interpret data from a specific source.
Find out more about NPDUIS data: